You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 10, October 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Antioxidants, Zinc, and Age-Related Macular Degeneration

Results and Recommendations

Arch Ophthalmol. 2001;119:1533-1534.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE PATIENTS arrive in our offices with plastic bottles and packets filled with pills of all sizes, shapes, and colors. In an attempt to prevent or ameliorate their age-related macular degeneration (AMD) they take vitamins including E, C, and A; minerals like zinc and selenium; carotenoids (beta carotene, lutein, zeaxanthin); and a variety of herbal supplements including gingko biloba and bilberry. They respond to articles in the lay press, in magazines, and on the internet, and to recommendations of their ophthalmologists and primary care physicians in hopes that these substances may help their AMD. Many take these, in addition to a myriad of other supplements for arthritis, vascular disease, and to prevent cancer. Many in the Baby Boom generation "attack" rather than wait for the inevitable progression of aging. They take these supplements prophylactically despite minimal or no signs of AMD. One ophthalmology colleague, a marathon runner, was taking some . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8
Age-Related Eye Disease Study Research Group
Arch Ophthalmol. 2001;119(10):1417-1436.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Age-Related Macular Degeneration
Seigel et al.
NEJM 2008;359:1735-1736.
FULL TEXT  

AREDS--Two Years Later
Jampol
Arch Ophthalmol 2003;121:1634-1636.
FULL TEXT  

Peripheral Pigmented Corneal Ring: A New Finding in Hypercarotenemia
Rahmani et al.
Arch Ophthalmol 2003;121:403-407.
FULL TEXT  

Antioxidants and Zinc to Prevent Progression of Age-Related Macular Degeneration
Jampol and Ferris
JAMA 2001;286:2466-2468.
FULL TEXT  

Antioxidants and Zinc for Age-Related Eye Diseases
JWatch General 2001;2001:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.